Shanghai Desano Pharmaceutical Group Co., Ltd.
PrivateLast Round
Private Equity
Feb 2, 2023
Company Overview
Shanghai Desano Pharmaceutical Group Co., Ltd. is a pharmaceutical company that engages in the research and development, manufacturing, and sales of high-quality pharmaceutical drugs, with a focus on treatments for HIV and malaria.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai Desano Pharmaceutical Group Co., Ltd. Comparables
Compare Shanghai Desano Pharmaceutical Group Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hetero Group | 84% | |
| Anhui Biochem United Pharmaceutical Co., Ltd. | 81% | |
| Laurus Labs Limited | 81% | |
Shanghai Desano Pharmaceutical Group Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Feb 2, 2023 | ||||
| Series A Extension | Mar 14, 2022 | ||||
| Strategic | Oct 31, 2014 | ||||
| Series A | Jan 1, 2011 | ||||
| Early Funding | Mar 1, 2010 |
Shanghai Desano Pharmaceutical Group Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Xingye Guoxin Asset Management | Private Equity |
| Lingang Blue Bay Capital | Series A Extension |
| Greenwoods Investments | Series A |
| PICC Capital Insurance Asset Management | Private Equity |
| Qiming Venture Partners | Early Funding, Private Equity |
| Zhenxiang Capital | Private Equity |
| 上海鼎嘉创业投资管理有限公司 | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 2, 2023
Led by CICC Jiatai Tianjin Equity Investment Fund Partnership and PICC Capital.
- Mar 1, 2010
Qiming Venture Partners participated in the early funding round.
Shanghai Desano Pharmaceutical Group Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Shanghai Desano Pharmaceutical Group Co., Ltd.'s valuation, stock price, and market status.